Sunrise Expands Footprint in Sleep Care Solutions
Sunrise, a frontrunner in sleep disorder diagnostics technology, is excited to announce its strategic plans to enhance the availability of sleep care in the United States. By integrating telehealth services and online care solutions, Sunrise is set to revolutionize the way individuals access sleep health resources.
Strategic Acquisition of Dreem Health
In a significant move, Sunrise has acquired Dreem Health, a notable California-based sleep clinic specializing in the diagnosis and treatment of sleep disorders. This acquisition aims to combine Sunrise's innovative diagnostic technology with Dreem Health's strong partnerships with major insurers and Medicare, making sleep care more accessible to those in need.
Investment for Growth
To date, Sunrise has raised over $35 million in capital from various investors, including Amazon's Alexa Fund and Kurma Partners. This financial backing serves as a catalyst for the company to further its mission of democratizing sleep health.
Leadership Changes to Drive Growth
In addition to the acquisition, Sunrise has appointed Laura Warnier as Chief Growth Officer. Warnier comes with an impressive track record from her previous role at EdTech Unicorn GoStudent, where she played a crucial role in expanding the business from zero to $200 million in revenue.
Building a Stronger Team
In her new position at Sunrise, Warnier is tasked with spearheading the company's sales and marketing efforts. With ambitious goals, she aims to scale Sunrise significantly, increase revenue, and establish it as the foremost sleep clinic in the nation.
Transforming Sleep Diagnostics
Warnier expressed her enthusiasm about joining Sunrise at a pivotal time, emphasizing the immense growth potential within the sleep care industry. Today, nearly 1 billion individuals worldwide struggle with sleep apnea, with 80 percent remaining undiagnosed. This presents a vast opportunity for Sunrise to lead the way in sleep disorder diagnosis and treatment.
Nationwide Expansion
Sunrise is making its groundbreaking sleep diagnostic tools accessible to millions across various states soon. With the partnership with Dreem Health, individuals can now receive evaluations and diagnoses using Sunrise’s at-home testing device. The company plans to expand nationally by 2025, aiming to provide personalized treatment plans or referrals based on individual needs.
About Sunrise
Founded in 2015, Sunrise has established itself as a leader in sleep diagnostics with its innovative chin sensor, which tracks jaw movements for comprehensive sleep analysis. The company has achieved significant milestones, including publishing breakthrough clinical results and expanding its team of experts from various fields, including sleep research and electronic design. With Dreem Health now onboard, Sunrise enhances its offerings beyond diagnostics, becoming a comprehensive resource for treating sleep issues. Headquartered in Belgium with additional offices in France and the U.S., Sunrise is prepared to take sleep health to the next level.
Frequently Asked Questions
What services does Sunrise provide?
Sunrise offers innovative sleep diagnostic tools and personalized treatment plans for individuals experiencing sleep disorders.
How does Sunrise's acquisition of Dreem Health impact its services?
The acquisition enables Sunrise to leverage Dreem Health's partnerships with insurers to increase access to sleep care across the nation.
What is the significance of Laura Warnier's appointment?
Laura Warnier's appointment as Chief Growth Officer is essential for driving Sunrise’s growth and enhancing its market presence in the U.S.
What challenges does the sleep care industry currently face?
Historically, the sleep care industry has been overlooked, resulting in a significant number of individuals remaining undiagnosed, especially with conditions like sleep apnea.
When will Sunrise services be available nationwide?
Sunrise aims to have its services available nationwide by 2025, expanding its market reach and accessibility to more individuals.
